AlphaSimPlex Group’s Exact Sciences EXAS Stock Holding History

AlphaSimPlex Group’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,016	Closed	-$279K	–	158
2019 Q4	$279K	Buy	+3,016	New	+$265K	0.11%	217

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AlphaSimPlex Group's EXAS Position: Q1 2020 in Review

AlphaSimPlex Group sold out of Exact Sciences (EXAS) in Q1 2020, closing a stake of 3,016 shares — an estimated $279K sold.

AlphaSimPlex Group first reported a position in EXAS in Q4 2019 and held it in 1 quarter. The position peaked at $279K in Q4 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

AlphaSimPlex Group reported no remaining Exact Sciences position as of Q1 2020 after selling out during the quarter.
AlphaSimPlex Group sold 3,016 Exact Sciences shares in Q1 2020, an estimated $279K.
AlphaSimPlex Group first reported a position in Exact Sciences in Q4 2019 and held it in 1 quarter.
AlphaSimPlex Group's Exact Sciences position peaked at $279K in Q4 2019.
475 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on AlphaSimPlex Group's 13F filing for Q1 2020, filed 13 May 2020.